Olin Corporation's 30-day narrative has been dominated by its announced all-stock merger with Huntsman Corporation, creating a $12.5 billion revenue chemical powerhouse through a merger of equals structure. The combination represents significant consolidation in the specialty chemicals sector, with both companies targeting $400 million in cost and revenue synergies by 2031. UBS analysis identifies cost savings as the primary value driver, emphasizing operational efficiencies from combining two mid-cap peers. The all-stock structure preserves shareholder value while eliminating equity dilution concerns, a critical factor supporting the bullish sentiment across coverage. The merger announcement itself serves as the primary catalyst, with the integration timeline and synergy realization extending through 2031. Sector-wide consolidation trends in materials and specialty chemicals support this deal logic. Forward implications hinge on successful integration execution and achieving stated synergy targets. Regulatory approval represents the primary near-term risk, while broader chemical industry cyclicality could impact medium-term profitability and synergy realization timelines.